Anne-Laure Sellier-Leclerc, Daniella Magen, Hadas Shasha-Lavsky, Eva Simkova, Arnaud Devresse, Fitsum Guebre-Egziabher, Mini Michael, John C Lieske, Yaacov Frishberg, Sevcan A Bakkaloglu, Chebl Mourani, Rola Saqan, Richard Singer, Isabella Guzzo, Nune Makarova, Richard Willey, Cristin Kaspar, John M Gansner, Jaap W Groothoff
{"title":"Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-Up of the Phase 3 Illuminate-C Trial.","authors":"Anne-Laure Sellier-Leclerc, Daniella Magen, Hadas Shasha-Lavsky, Eva Simkova, Arnaud Devresse, Fitsum Guebre-Egziabher, Mini Michael, John C Lieske, Yaacov Frishberg, Sevcan A Bakkaloglu, Chebl Mourani, Rola Saqan, Richard Singer, Isabella Guzzo, Nune Makarova, Richard Willey, Cristin Kaspar, John M Gansner, Jaap W Groothoff","doi":"10.1053/j.ajkd.2025.01.016","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":" ","pages":""},"PeriodicalIF":9.4000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Kidney Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1053/j.ajkd.2025.01.016","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
期刊介绍:
The American Journal of Kidney Diseases (AJKD), the National Kidney Foundation's official journal, is globally recognized for its leadership in clinical nephrology content. Monthly, AJKD publishes original investigations on kidney diseases, hypertension, dialysis therapies, and kidney transplantation. Rigorous peer-review, statistical scrutiny, and a structured format characterize the publication process. Each issue includes case reports unveiling new diseases and potential therapeutic strategies.